Sort   by:  
 Page size 
UnknownFollicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.
Not available
S-EPMC3709054 | biostudies-literature
UnknownQuantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.
Not available
S-EPMC3397783 | biostudies-literature
GenomicsLoss of imprinting at the CTCF binding sites in the DLK1-DIO3 domain reactivates microRNA expression in acute promyelocytic leukaemia
We report the DNA-methylation profiling of 10 regions selected from the DLK1-DIO3 domain on chromosome 14q32 in BM/PB samples from patients with acute promyelocytic leukaemia (APL), other subclasses of acute myeloid leukaemia and healthy donors, using high-throughput amplicon bisulfite sequencing wi...
ORGANISM(S): Homo sapiens 
2014-02-13 | E-GEOD-42543 | biostudies-arrayexpress
UnknownRandomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).
Not available
S-EPMC5420789 | biostudies-literature
UnknownCRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and shapes immune progeny.
Not available
S-EPMC10450654 | biostudies-literature
UnknownRole of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.
Not available
S-EPMC4980557 | biostudies-literature
ProteomicsEffects of FTY720 on phospho-proteome of leukemic cells
: FTY720 (Fingolimod) is an immunosuppressive drug approved by FDA for Multiple Sclerosis (MS), that has gained attention as anti-cancer drug, thanks to its ability to disrupt the binding between the onco-protein SET and the tumor- suppressor phosphatase PP2A. We investigated FTY720 induced phospho...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD038288 | Pride
Fty720 Pp2a Phosphoproteomics Set Fingolimod Aml Lc-ms/ms 
Genomicsena-DATASET-VUMC-CCA-12-10-2016-16:43:39:044-188 - samples
Background: In follicular lymphoma (FL), studies addressing the prognostic value of microenvironment-related immunohistochemical (IHC) markers and tumor cell-related genetic markers have yielded conflicting results, precluding implementation in practice. Therefore, the Lunenburg Lymphoma Biomarker C...
EGAD00001002738 | EGA
GenomicsPrognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Background: In follicular lymphoma (FL), studies addressing the prognostic value of microenvironment-related immunohistochemical (IHC) markers and tumor cell-related genetic markers have yielded conflicting results, precluding implementation in practice. Therefore, the Lunenburg Lymphoma Biomarker C...
EGAS00001002049 | EGA
Genomicsena-DATASET-BCI-18-03-2015-12:48:54:303-380 - samples
Whole exome sequencing data of 5 patients diagnosed with FL that had undergone several relapse episodes without evidence of transformation
EGAD00001001301 | EGA
Sort   by:  
 Page size